Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improved survival in women with BRCA-associated ovarian carcinoma.

Cancer - 1 May 2003

Cass Ilana, Baldwin Rae Lynn, Varkey Taz, Moslehi Roxana, Narod Steven A, Karlan Beth Y

Abstract excerpt

BACKGROUND: The objective of this study was to determine the clinical characteristics, treatment response, and frequency of p53 overexpression in Ashkenazi Jewish women with hereditary ovarian carcinoma. METHODS: Seventy-one Jewish women with epithelial ovarian carcinoma (EOC) were tested for the three BRCA founder mutations using single-strand conformation polymorphism analysis, heteroduplex analysis, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to California
Share to Disease-Free Survival
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genes, p53

Share to Neoplasm Recurrence, Local

Share to Survival Rate

Source

Identifiers

PMID: 12712470
DOI: 10.1002/cncr.11310

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improved survival in women with BRCA-associated ovarian carcinoma.PMID 12712470Read ↗

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.Semantic proximity Read ↗

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.Semantic proximity Read ↗

Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer.Semantic proximity Read ↗

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.Semantic proximity Read ↗

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.Semantic proximity Read ↗

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

Differential Contributions of<i>BRCA1</i>and<i>BRCA2</i>to Early-Onset Breast CancerSemantic proximity Read ↗

Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.Semantic proximity Read ↗

Effect of BRCA germline mutations on breast cancer prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.